EGFR Inhibitors Reshape Oncologic Paradigms Worldwide The Epidermal Growth Factor Receptor (EGFR) is a transmembrane protein involved in vital cellular processes, including proliferation and survival. In many types of cancer, especially those of epithelial origin, abnormalities in EGFR expression or function contribute to tumor development and progression. Targeted therapies aimed at blocking EGFR have become a critical part of the cancer...